Skip to content

Early-life mucosal T cells direct intestinal stem cell fate via a coordinated developmental program 2305986

Jul 2026 · Journal of Immunology · 0 citations

Abstract

Although early-life immunity was once considered immature, the human fetal immune system is dynamic and compartmentalized by the 2nd trimester. By the 21st gestational week, T lymphocytes dominate the fetal small intestine (SI), yet their mucosal functions prenatally are unclear. Because fetal T cell infiltration is concomitant with rapid intestinal epithelial growth and differentiation in utero, we hypothesized that early-life intestinal T cells support normal mucosal development and function. We generated an ex vivo co-culture model where SI T cells from fetal or adult donors are integrated with SI organoids, assessing organoid generation and differentiation by microscopy, single-cell RNA sequencing, and multiplexed cytokine assays. To complement our ex vivo approach, we also performed spatial transcriptomics on healthy and diseased SI tissue to investigate T cell-epithelial interactions throughout the human lifespan. Fetal SI T cells significantly promoted organoid generation and cell cycling gene programs, even in organoids derived from adults or diseased neonates, suggesting they can reprogram the epithelium towards a regenerative state. Uniquely, fetal SI T cells also directed intestinal stem cell (ISC) differentiation towards the secretory lineage. Yet, adult SI T cells did not support organoid growth or differentiation, highlighting specialized roles of fetal T cells. To test whether secreted factors direct ISC fate, we cultured organoids with T cell-derived conditioned media, which was insufficient to stimulate organoid generation. Additionally, fetal SI T cells were significantly more likely to localize near ISCs, supporting the need for physical interactions. Overall, we report a unique and coordinated developmental program where fetal SI T cells shape ISC programming by balancing growth and differentiation, offering a new therapeutic angle for intestinal diseases where these processes are disrupted. NIH AI171980, AI179570; NIH P30DK034854-36; YSM Science Fellows 2024 Program and Grant; Yale Department of Pediatrics Trainee Pilot Grant Mucosal and Regional Immunology (MUC)

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.